Article 2026-04-23 posted v1

An adipocyte-endothelial framework to identify molecular signatures of metabolic vulnerability in obesity

V
Vaishali Chaurasiya Minerva Foundation Institute for Medical Research, and Doctoral Programme in Clinical Research, University of Helsinki – Helsinki, Finland
L
Luyang Li Division of Infection and Immunity, School of Medicine, and Systems Immunity Research Institute, Cardiff University – Cardiff, United Kingdom
A
Aina Lluch Girona Biomedical Research Institute (IDIBGI), and CIBER de la Fisiología de la Obesidad y la Nutrición (CIBEROBN) – Girona, Spain
A
Ana Fernández-Sánchez Girona Biomedical Research Institute (IDIBGI) – Girona, Spain
J
Jukka Harju Department of Gastrointestinal Surgery, Abdominal Center, University of Helsinki and Helsinki University Hospital – Helsinki, Finland
D
Dan Duc Pham Minerva Foundation Institute for Medical Research – Helsinki, Finland
S
Sanni Perttunen Minerva Foundation Institute for Medical Research – Helsinki, Finland
S
Salla Keskitalo Molecular Systems Biology Research Group & Proteomics Unit, HiLIFE Helsinki Institute of Life Science, Institute of Biotechnology, University of Helsinki – Helsinki, Finland
M
Markku Varjosalo Molecular Systems Biology Research Group & Proteomics Unit, HiLIFE Helsinki Institute of Life Science, Institute of Biotechnology, University of Helsinki – Helsinki, Finland
K
Kirsi H. Pietiläinen Obesity Research Unit, Research Program for Clinical and Molecular Metabolism, and HealthyWeightHub, Endocrinology, Abdominal Center, Helsinki University Hospital, University of Helsinki – Helsinki, Finland
P
P.A. Nidhina Haridas Minerva Foundation Institute for Medical Research – Helsinki, Finland
J
José-Maria Moreno-Navarrete Girona Biomedical Research Institute (IDIBGI), CIBER de la Fisiología de la Obesidad y la Nutrición (CIBEROBN), and School of Medicine, University of Girona – Girona, Spain
J
José I. Rodríguez-Hermosa Girona Biomedical Research Institute (IDIBGI), and School of Medicine, University of Girona – Girona, Spain
E
Encarna Piedrafita-Serra Girona Biomedical Research Institute (IDIBGI), and School of Medicine, University of Girona – Girona, Spain
A
Asha Kar Bioinformatics Interdepartmental Program, and Institute for Precision Health, David Geffen School of Medicine, UCLA – Los Angeles, USA
P
Päivi Pajukanta Bioinformatics Interdepartmental Program, and Institute for Precision Health, David Geffen School of Medicine at UCLA – Los Angeles, USA
M
Markku Laakso Institute of Clinical Medicine, University of Eastern Finland and Kuopio University Hospital – Kuopio, Finland
V
Ville Männistö Institute of Clinical Medicine, University of Eastern Finland and Kuopio University Hospital – Kuopio, Finland
J
Jussi Pihlajamäki Institute of Public Health and Clinical Nutrition, University of Eastern Finland and Kuopio University Hospital – Kuopio, Finland
M
Minna U. Kaikkonen A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland – Kuopio, Finland
G
Gema Frühbeck Instituto de Investigación Sanitaria de Navarra (IdISNA), Clínica Universidad de Navarra, and CIBER de la Fisiología de la Obesidad y la Nutrición – Pamplona, Spain
O
Oriol A. Rangel-Zúñiga Maimónides Biomedical Research Institute of Córdoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, and CIBER de la Fisiología de la Obesidad y la Nutrición – Córdoba, Spain
F
Francisco José Tinahones Instituto de Investigación Biomédica de Málaga (IBIMA), Virgen de la Victoria Hospital, University of Málaga, and CIBER de la Fisiología de la Obesidad y la Nutrición – Málaga, Spain
C
Carlos Dieguez Center for Research in Molecular Medicine and Chronic Diseases (CiMUS, University of Santiago de Compostela, Instituto de Investigación Sanitaria, CIBER de la Fisiología de la Obesidad y la Nutrición – Santiago de Compostela, Spain
R
Ralph Burkhardt Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg – Regensburg, Germany
M
Marcus Höring Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg – Regensburg, Germany
G
Gerhard Liebisch Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg – Regensburg, Germany
J
Johanna Pörschke Institute for Tumor Immunology, Center for Tumor Biology and Immunology, Marburg University – Marburg, Germany
M
María Gómez-Serrano Institute for Tumor Immunology, Center for Tumor Biology and Immunology, Marburg University – Marburg, Germany
J
Johannes Graumann Institute of Translational Proteomics & Core Facility, Marburg University – Marburg, Germany
W
Witold Szymanski Institute of Translational Proteomics & Core Facility, Marburg University – Marburg, Germany
J
José-Manuel Fernández-Real Girona Biomedical Research Institute (IDIBGI), CIBER de la Fisiología de la Obesidad y la Nutrición (CIBEROBN), and School of Medicine, University of Girona – Girona, Spain
Y
You Zhou Division of Infection and Immunity, School of Medicine, and Systems Immunity Research Institute, Cardiff University – Cardiff, United Kingdom
V
Vesa Olkkonen Minerva Foundation Institute for Medical Research, and Department of Anatomy, Faculty of Medicine, University of Helsinki – Helsinki, Finland
F
Francisco Ortega Girona Biomedical Research Institute (IDIBGI), and CIBER de la Fisiología de la Obesidad y la Nutrición (CIBEROBN) – Girona, Spain

Abstract

Obesity-related metabolic disease is linked to impaired adipose tissue function, but the underlying molecular programs are difficult to assign to specific adipose-resident cell types, to mechanistically connect to inflammation, and to distinguish from alterations that normalize with weight loss. We integrated here a layered design combining untargeted proteomics and lipidomics to define obesity-associated, cell-type-resolved molecular phenotypes across isolated adipocytes and adipose microvascular endothelial cells, explore whether an obesity-like inflammatory milieu reproduces adipose-resident cell dysfunction, and identify molecular features that show evidence of recovery after surgery-induced weight loss. As expected, adipocytes from people with obesity show suppression of mitochondrial energy metabolism together with impaired lipid plasticity, as reflected by triglyceride remodelling. By mimicking an obesity-like inflammatory milieu with macrophage-conditioned media, we reproduced most of these changes in adipocyte cultures. Endothelial cells exhibited yet another, opposite trajectory in obesity, with reduced cell-cycle signalling and increased mitochondrial activation, which were recapitulated in vitro when these cells were exposed, respectively, to the secretions of inflamed macrophages and adipocytes. Bulk adipose tissue proteomes and lipidomes showed evidence of metabolic improvement after weight loss, with broad restoration of mitochondrial and substrate-handling pathways and reciprocal triglyceride remodelling. Alongside the inflammation-responsive adipocyte mitochondrial and lipid-handling dysfunction, our cell-type-informed framework probes macrophage and adipocyte-to-endothelial activation in obesity and delineates cross-context cellular programs that recover with weight loss. Additionally, we identified the elements that exhibit the strongest association with dyslipidaemia, hypertriglyceridemia and hyperglycaemia in individuals with obesity, confirming molecular signatures relevant to metabolic obesity in two cross-sectional samples. Vaishali Chaurasiya, Luyang Li, Aina Lluch participated equally

Citation Information

@article{vaishalichaurasiya2026,
  title={An adipocyte-endothelial framework to identify molecular signatures of metabolic vulnerability in obesity},
  author={Vaishali Chaurasiya and Luyang Li and Aina Lluch and Ana Fernández-Sánchez and Jukka Harju and Dan Duc Pham and Sanni Perttunen and Salla Keskitalo and Markku Varjosalo and Kirsi H. Pietiläinen and P.A. Nidhina Haridas and José-Maria Moreno-Navarrete and José I. Rodríguez-Hermosa and Encarna Piedrafita-Serra and Asha Kar and Päivi Pajukanta and Markku Laakso and Ville Männistö and Jussi Pihlajamäki and Minna U. Kaikkonen and Gema Frühbeck and Oriol A. Rangel-Zúñiga and Francisco José Tinahones and Carlos Dieguez and Ralph Burkhardt and Marcus Höring and Gerhard Liebisch and Johanna Pörschke and María Gómez-Serrano and Johannes Graumann and Witold Szymanski and José-Manuel Fernández-Real and You Zhou and Vesa Olkkonen and Francisco Ortega},
  journal={Research Square},
  year={2026},
  doi={https://doi.org/10.21203/rs.3.rs-9485802/v1}
}
Back to Top
Home
Paper List
Submit
0.019015s